Clinical Trial

Effects of Senobi Exercise & Aerobic Exercises in Polycystic Ovarian Syndrome

Study acronym: CESAEBMIFQPCOS
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated January 8, 2026 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
One of the most prevalent endocrine system conditions affecting women of reproductive age is polycystic ovary syndrome (PCOS), also known as hyperandrogenic anovulation (HA) or Stein-Leventhal syndrome. This chronic and heterogeneous disorder manifests itself as menstrual dysfunction, infertility, hirsutism, acne, and obesity. This study will be randomized controlled trial and will be conducted in Qasim Sandhu medical complex, Iiffat Anwar Medical Complex and OMC Hospital Lahore. Data will be collected 10 months after approval of synopsis. The total duration of treatment will be 6 weeks. Non-probability convenience sampling technique will be used and 32 participants will be recruited in study after randomization according to selection criteria. The subjects will be divided into two groups, 16 participants in each group. Group A (experimental group) will receive senobi exercises and aerobic exercises, 3 days\\week for 6 weeks and Group B (control group) will receive aerobic exercises, 3days\\week for 6 week.
Trial Details
NCT Number NCT07328048
Lead Sponsor Riphah International University
Conditions Polycystic Ovarian Syndrome Females
Enrollment 32 participants
Start Date 2026-01
Primary Completion 2026-03 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-08